Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Role of the Motor in Motor Neuron Diseases
2 May 2003. In today's Science, researchers report that mutations in the protein dynein-the motor that drives the transport of large molecules from the synaptic terminal back to the neuron’s cell body-can lead to forms of neurodegeneration reminiscent of motor neuron diseases such as amyotrophic lateral sclerosis (ALS).

This is not the first evidence implicating axonal transport in neurodegenerative disease. Loss or interference with the protein dynactin, a component of the motor complex, has previously been shown to result in poor retrograde transport and the complete loss of axons in mice (see ARF related news story). Axonal transport is also implicated in Alzheimer’s (see ARF related news story; also ARF story). Now, a multinational collaboration led by Elizabeth Fisher at the National Hospital for Neurology and Neurosurgery in London, U.K., reports that Legs at odd angles (Loa) and Cramping 1 (Cra1), two chemically-induced mutations that cause progressive loss of locomotor function, are actually point mutations in the heavy chain of cytoplasmic dynein-the Loa mutation being a change from phenylalanine at position 580 to tyrosine, while Cra1 results from a tyrosine-to-cysteine switch at position 1,055 of the protein.

Joint first authors Majid Hafezparast and Rainer Klocke characterized these two mutations and found that dynein levels are unaltered in both homozygous and heterozygous animals as compared to wild-type controls. The authors also found that the Golgi apparatus, a subcellular production line for protein modification and maturation that relies on dynein for protein conveyance, appeared normal in Loa homozygotes. However, when nocodazole was used to disrupt the apparatus, its reassembly was compromised in Loa mice. It is worth noting that in human ALS, the Golgi apparatus has been reported to be extensively fragmented, much like in nocodazole-treated cells.

Hafezparast and colleagues also found that motor neurons, especially those controlling facial muscles, fail to develop normally in Loa mutants. This is significant because facial motor weakness is a hallmark of spinal-bulbar muscular atrophy and some subtypes of ALS. To discover if axonal transport is compromised in these mutants, the authors visualized retrograde axonal transport using a fragment of tetanus toxin as a fluorescent marker. When Hafezparast and Klocke added the tetanus fragment to motor neurons cultured from Loa mutants, they found that retrograde transport was significantly slower than in control neurons. For example, the number of tetanus fragments moving along the axons at high speed was reduced to less than half, while the number of fragments that appeared to be stationary was more than doubled. Because dynein is involved in many other cellular processes, such as cell division, the latter results are key to linking dynein activity, retrograde transport, and loss of neuronal function.-Tom Fagan.

Reference:
Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, Bowen S, Lalli G, Witherden AS, Hummerich H, Nicholson S, Morgan PJ, Oozageer R, Priestley JV, Averill S, King VR, Ball S, Peters J, Toda T, Yamamoto A, Hiraoka Y, Augustin M, Korthaus D, Wattler S, Wabnitz P, Dickneite C, Lampel S, Boehme F, Peraus G, Popp A, Rudelius M, Schlegel J, Fuchs H, de Angelis MH, Schiavo G, Shima DT, Russ AP, Stumm G, Martin JE, Fisher EMC. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 2003 May 2;300:808-812. Abstract

 
Comments on News and Primary Papers
  Primary Papers: Mutations in dynein link motor neuron degeneration to defects in retrograde transport.

Comment by:  Takaomi Saido, ARF Advisor
Submitted 12 June 2003  |  Permalink Posted 13 June 2003
  I recommend this paper

This work further confirms the importance of axonal retrograde transport in the development of neurodegeneration (at least in motor neuron degeneration). Although whether the concept applies to Alzheimer research remains to be examined, it seems worth trying.

View all comments by Takaomi Saido
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad